Profile picture

Doctor Vincent Algalarrondo

Hospital Bichat-Claude Bernard, Paris (France)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Artificial intelligence to assist the echocardiographic identification of transthyretin cardiac amyloidosis
Presentation
Artificial intelligence to assist the echocardiographic identification of transthyretin cardiac amyloidosis
Tafamidis versus liver transplantation as first-line therapy for hereditary transthyretin amyloidosis
Presentation
Tafamidis versus liver transplantation as first-line therapy for hereditary transthyretin amyloidosis
Surviving at least one year with a good functional status: analysis of the early deaths after primary implantation of intracardiac defibrillator.
Presentation
Surviving at least one year with a good functional status: analysis of the early deaths after primary implantation of intracardiac defibrillator.
Atrial fibrillation ablation.
Presentation
Atrial fibrillation ablation.
Autonomic dysfunction and prediction of long term survival in transthyretin amyloidosis
Presentation
Autonomic dysfunction and prediction of long term survival in transthyretin amyloidosis

ESC 365 is supported by